Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
A hybrid breast cancer/mesenchymal stem cell population enhances chemoresistance and metastasis
Giuseppina Augimeri, Maria E. Gonzalez, Alessandro Paolì, Ahmad Eido, Yehyun Choi, Boris Burman, Sabra Djomehri, Santhosh Kumar Karthikeyan, Sooryanarayana Varambally, Johanna M. Buschhaus, Yu-Chih Chen, Loredana Mauro, Daniela Bonofiglio, Alexey I. Nesvizhskii, Gary D. Luker, Sebastiano Andò, Euisik Yoon, Celina G. Kleer
Giuseppina Augimeri, Maria E. Gonzalez, Alessandro Paolì, Ahmad Eido, Yehyun Choi, Boris Burman, Sabra Djomehri, Santhosh Kumar Karthikeyan, Sooryanarayana Varambally, Johanna M. Buschhaus, Yu-Chih Chen, Loredana Mauro, Daniela Bonofiglio, Alexey I. Nesvizhskii, Gary D. Luker, Sebastiano Andò, Euisik Yoon, Celina G. Kleer
View: Text | PDF
Research Article Cell biology Oncology

A hybrid breast cancer/mesenchymal stem cell population enhances chemoresistance and metastasis

  • Text
  • PDF
Abstract

Patients with triple-negative breast cancer remain at risk for metastatic disease despite treatment. The acquisition of chemoresistance is a major cause of tumor relapse and death, but the mechanisms are far from understood. We have demonstrated that breast cancer cells (BCCs) can engulf mesenchymal stem/stromal cells (MSCs), leading to enhanced dissemination. Here, we show that clinical samples of primary invasive carcinoma and chemoresistant breast cancer metastasis contain a unique hybrid cancer cell population coexpressing pancytokeratin and the MSC marker fibroblast activation protein-α. We show that hybrid cells form in primary tumors and that they promote breast cancer metastasis and chemoresistance. Using single-cell microfluidics and in vivo models, we found that there are polyploid senescent cells within the hybrid cell population that contribute to metastatic dissemination. Our data reveal that Wnt Family Member 5A (WNT5A) plays a crucial role in supporting the chemoresistance properties of hybrid cells. Furthermore, we identified that WNT5A mediates hybrid cell formation through a phagocytosis-like mechanism that requires BCC-derived IL-6 and MSC-derived C-C Motif Chemokine Ligand 2. These findings reveal hybrid cell formation as a mechanism of chemoresistance and suggest that interrupting this mechanism may be a strategy in overcoming breast cancer drug resistance.

Authors

Giuseppina Augimeri, Maria E. Gonzalez, Alessandro Paolì, Ahmad Eido, Yehyun Choi, Boris Burman, Sabra Djomehri, Santhosh Kumar Karthikeyan, Sooryanarayana Varambally, Johanna M. Buschhaus, Yu-Chih Chen, Loredana Mauro, Daniela Bonofiglio, Alexey I. Nesvizhskii, Gary D. Luker, Sebastiano Andò, Euisik Yoon, Celina G. Kleer

×

Figure 2

MSC engulfment by breast cancer cells (BCCs) generates a hybrid polyploid population characterized by a senescent phenotype.

Options: View larger image (or click on image) Download as PowerPoint
MSC engulfment by breast cancer cells (BCCs) generates a hybrid polyploi...
(A) Schematic representation of BCCs cultured with MSCs to obtain hybrid-enriched population. (B) Representative flow cytometry live imaging stream pictures showing a Ki67lo hybrid cell. GFP-labeled MDA-MB-231 (GFP-231) BCCs were cultured with DsRed-labeled MSCs (DsRed-MSCs) for 72 hours and stained with Ki67 antibody. Ki67lo cells were sorted and fixed, and nuclei were stained with DAPI. An overlay of all fluorescence channels shows a multinucleated GFP+/DsRed+ hybrid cell. Cell phase image (bright-field [BF]) is included to display cell morphology. (C) Cell-cycle analysis by flow cytometry in the coculture of GFP-231 BCCs with DsRed-MSCs after 72 hours showing the emergence of a polyploid population in GFP+/DsRed+ (hybrid) compared with GFP+ cells. Bar graph shows the quantification of the flow cytometry analyses. (D) ELISA analyses of IL-6, CCL2, OPN, THBS1, and uPAR in supernatants of GFP-231 BCCs and MSCs diluted 1:1 (GFP-231) or in coculture (GFP-231 + DsRed-MSC). (E) Senescence-associated β-Gal (SA–β-Gal) activity analyzed by flow cytometry using DsRed-labeled MDA-MB-231 cells (DsRed-231) and MSC (unlabeled) in single cultures and cocultures for 1 week. Bar graph shows the percent of SA–β-Gal/DsRed+ cells. (F) Lung metastases from mice injected intracardially with GFP-231 or GFP+/FAP+ hybrid cells sorted by FACS, stained with H&E and SA–β-Gal by IHC (n = 3 per group). Bar graph shows the quantification of the SA–β-Gal in 5 different fields per condition (n = 4 per group) using ImageJ. Scale bars: 20 µm. For all panels, data are shown as individual values with mean ± SEM. In C, D, and F, 2-tailed unpaired Student’s t test was employed; in E, 1-way ANOVA with Tukey’s multiple comparison test was employed. *P < 0.05; **P < 0.005; ***P < 0.0005; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts